These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21692850)

  • 1. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
    Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E
    Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
    Jimenez-Zepeda VH; Braggio E; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
    Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
    Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
    Chng WJ; Ketterling RP; Fonseca R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
    Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
    Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
    Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
    Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomes in plasma-cell malignancies.
    Van Den Berghe H
    Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
    Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
    Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
    Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
    Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
    d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
    Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
    Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.